Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre Strydom

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Journal of Affective Disorders|July 6, 2013
Manualised Individual Cognitive Behavioural Therapy for mood disorders in people with mild to moderate intellectual disability: a feasibility randomised controlled trialAngela Hassiotis, Marc Serfaty, Kiran Azam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Predonation health-related quality of life scores predict time to recovery in hematopoietic stem cell donorsAnnelies Billen, J Alejandro Madrigal, Andre Strydom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 23, 2020
Optimal age and outcome measures for Alzheimer's disease prevention trials in people with Down syndromeRosalyn Hithersay, R Asaad Baksh, Carla M Startin, et al.
Plos Medicine|March 20, 2023
Recording of intellectual disability in general hospitals in England 2006-2019: Cohort study using linked datasetsRory Sheehan, Hassan Mansour, Matthew Broadbent, et al.
Journal of Intellectual Disabilities : JOID|July 20, 2024
Constipation prevalence and risk from prescribed medications in people with intellectual disability: Findings from an English mortality programmeChristina Roberts, Jonathon Ding, Delia Bishara, et al.
Plos One|June 6, 2014
Memory decline in Down syndrome and its relationship to iPF2alpha, a urinary marker of oxidative stressPanagiotis Zis, Patrick McHugh, Andrew McQuillin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 4, 2018
Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndromeCarla M Startin, Sarah Hamburg, Rosalyn Hithersay, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2019
Reply to "Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management"Carla M Startin, Sarah Hamburg, Rosalyn Hithersay, et al.
Diabetes Care|September 30, 2022
Diabetes and Obesity in Down Syndrome Across the Lifespan: A Retrospective Cohort Study Using U.K. Electronic Health RecordsAisha A Aslam, R Asaad Baksh, Sarah E Pape, et al.
The Lancet. Public Health|April 29, 2023
Multiple morbidity across the lifespan in people with Down syndrome or intellectual disabilities: a population-based cohort study using electronic health recordsR Asaad Baksh, Sarah E Pape, Li F Chan, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Journal of Affective Disorders|July 6, 2013
Manualised Individual Cognitive Behavioural Therapy for mood disorders in people with mild to moderate intellectual disability: a feasibility randomised controlled trialAngela Hassiotis, Marc Serfaty, Kiran Azam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Predonation health-related quality of life scores predict time to recovery in hematopoietic stem cell donorsAnnelies Billen, J Alejandro Madrigal, Andre Strydom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 23, 2020
Optimal age and outcome measures for Alzheimer's disease prevention trials in people with Down syndromeRosalyn Hithersay, R Asaad Baksh, Carla M Startin, et al.
Plos Medicine|March 20, 2023
Recording of intellectual disability in general hospitals in England 2006-2019: Cohort study using linked datasetsRory Sheehan, Hassan Mansour, Matthew Broadbent, et al.
Journal of Intellectual Disabilities : JOID|July 20, 2024
Constipation prevalence and risk from prescribed medications in people with intellectual disability: Findings from an English mortality programmeChristina Roberts, Jonathon Ding, Delia Bishara, et al.
Plos One|June 6, 2014
Memory decline in Down syndrome and its relationship to iPF2alpha, a urinary marker of oxidative stressPanagiotis Zis, Patrick McHugh, Andrew McQuillin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 4, 2018
Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndromeCarla M Startin, Sarah Hamburg, Rosalyn Hithersay, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2019
Reply to "Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management"Carla M Startin, Sarah Hamburg, Rosalyn Hithersay, et al.
Diabetes Care|September 30, 2022
Diabetes and Obesity in Down Syndrome Across the Lifespan: A Retrospective Cohort Study Using U.K. Electronic Health RecordsAisha A Aslam, R Asaad Baksh, Sarah E Pape, et al.
The Lancet. Public Health|April 29, 2023
Multiple morbidity across the lifespan in people with Down syndrome or intellectual disabilities: a population-based cohort study using electronic health recordsR Asaad Baksh, Sarah E Pape, Li F Chan, et al.
Pageof 12